$21.61
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Kiniksa Pharmaceuticals
KNSANASDAQ
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock, Earnings Estimates, EPS, And Revenue
Kiniksa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 30
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$91.1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$301.8M
Analyze the earnings history of Kiniksa Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals | -$0.02 | -$0.04 | — | — | $71.47M | $91.11M | — | — | 07/30/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.18 | -$0.16 | -$0.25 | -56.25% | $48.34M | $78.46M | $79.86M | 1.78% | 04/23/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | $0.06 | -$0.14 | $0.35 | 350.00% | $61.88M | $72.02M | $83.39M | 15.79% | 02/28/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | $3.18 | -$0.17 | -$0.20 | -17.65% | $99.14M | $64.45M | $67.05M | 4.03% | 10/31/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.29 | -$0.17 | -$0.02 | 88.24% | $26.97M | $52.20M | $71.47M | 36.92% | 07/25/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.36 | -$0.21 | -$0.18 | 14.29% | $32.19M | $46.58M | $48.34M | 3.79% | 05/02/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.53 | -$0.23 | $0.06 | 126.09% | $18.75M | $45.11M | $61.88M | 37.18% | 02/28/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.44 | $0.50 | $3.18 | 536.00% | $12.10M | $74.39M | $99.14M | 33.26% | 11/01/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.61 | -$0.44 | -$0.29 | 34.09% | $7.70M | $28.55M | $26.97M | -5.53% | 08/03/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.72 | -$0.41 | -$0.36 | 12.20% | $0.00 | $22.77M | $32.19M | 41.37% | 05/03/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.79 | -$0.42 | -$0.53 | -26.19% | $0.00 | $20.72M | $18.75M | -9.53% | 02/22/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.66 | -$0.65 | -$0.44 | 32.31% | $0.00 | $10.18M | $12.10M | 18.81% | 11/01/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.65 | -$0.79 | -$0.61 | 22.78% | $0.00 | $3.97M | $7.70M | 94.06% | 08/03/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.48 | -$0.80 | -$0.72 | 10.00% | $0.00 | $3.72M | $0.00 | -100.00% | 05/04/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.58 | — | -$0.79 | — | $0.00 | — | $0.00 | — | 02/23/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.49 | — | -$0.66 | — | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.68 | — | -$0.65 | — | $0.00 | — | $0.00 | — | 07/30/2020 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$1.27 | -$0.63 | -$0.48 | 23.81% | $0.00 | — | $0.00 | — | 04/28/2020 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.88 | — | -$0.58 | — | $0.00 | — | $0.00 | — | 02/26/2020 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.51 | — | -$0.49 | — | $0.00 | — | $0.00 | — | 10/28/2019 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.97 | -$0.72 | -$0.68 | 5.56% | $0.00 | — | $0.00 | — | 08/12/2019 | Get Alert |
Kiniksa Pharmaceuticals (KNSA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-23 | $-0.25 | $-0.16 | -56.3 % |
| Dec 2023 | 2024-02-28 | $0.35 | $-0.14 | 350.0 % |
| Sep 2023 | 2023-10-31 | $-0.20 | $-0.17 | -17.6 % |
| Jun 2023 | 2023-07-25 | $-0.02 | $-0.17 | 88.2 % |
Kiniksa Pharmaceuticals (KNSA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-23 | $79.86M | $78.46M | 1.78 % |
| Dec 2023 | 2024-02-28 | $83.40M | $72.02M | 15.8 % |
| Sep 2023 | 2023-10-31 | $67.05M | $64.45M | 4.03 % |
| Jun 2023 | 2023-07-25 | $71.47M | $52.20M | 36.9 % |
FAQ
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
Kiniksa Pharmaceuticals (KNSA) is scheduled to report earnings on July 30, 2024. The last reported earnings were for reported on April 23, 2024 for Q1.
What were the latest earnings per share (EPS) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)?
The Actual EPS was $-0.25, which missed the estimate of $-0.16.
What were Kiniksa Pharmaceuticals’s (NASDAQ:KNSA) revenues?
The Actual Revenue was $79.9M, which beat the estimate of $78.5M.
Browse earnings estimates, EPS, and revenue on all stocks.